Tag Archives: Antidepressants for Depression in Dementia (HTA-SADD)

Recent Elderly Mental Health-Related Systematic Reviews and Meta-Analyses

Posted on August 15, 2014 by Dementia and Elderly Care News

Some of the following articles may be available freely where indicated (depending on local circumstances). Access to the full-text of the other articles will require a suitable Athens password, a journal subscription or payment. The Bibliographic Citations Leong, C. (2014). … Continue reading →

Posted in Depression, For Doctors (mostly), For Researchers (mostly), International, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Pharmacological Treatments, Systematic Reviews | Tagged Agitation, Antidepressants, Antidepressants for Depression in Dementia, Antidepressants for Depression in Dementia (HTA-SADD), Anxiety, Apathy, Behavioural and Psychological Symptoms of Dementia (BPSD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, C9orf72, Dextromethorphan / Quinidine (DM/Q: Nuedexta™), Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V), Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV), Dronabinol, DSM-5, Frontotemporal Dementia, GRN, Impulse Control Disorder, Neurocognitive Disorders, Neuropsychiatric Symptoms in Alzheimer’s Disease, Non-Motor Fluctuations in Parkinson's Disease, Pick’s Disease (Frontotemporal Dementia), Pseudobulbar Affect (PBA), Psychological Symptoms of Dementia (BPSD), Psychosis in Frontotemporal Dementia, Sleep Disturbances, Visual Hallucinations | Leave a comment

Sertraline or Mirtazapine Versus a Placebo for Treatment of Depression in Dementia (HTA-SADD Trial)

Posted on March 10, 2013 by Dementia and Elderly Care News

Summary This randomised control trial took place across nine English old-age psychiatry units. It examined the clinical effectiveness of sertraline and mirtazapine in reducing depression compared with a placebo. 326 patients with Alzheimer’s Disease (AD), depression and a Cornell Scale … Continue reading →

Posted in Acute Hospitals, Community Care, Depression, For Doctors (mostly), For Researchers (mostly), Management of Condition, Mental Health, National, NHS, Pharmacological Treatments, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged Alzheimer's Society, Antidepressants, Antidepressants for Depression in Dementia (HTA-SADD), Behavioral and Psychological Symptoms of Dementia (BPSD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Brighton and Sussex Medical School: University of Sussex, Burden of Dementia, Burden on Caregivers, Caregiving (Carers), Carers, Cornell Scale for Depression in Dementia (CSDD), Dementia Quality of Life (DEMQOL), DEMQOL-Proxy, Department of Community Based Medicine, Department of Mental Health Sciences: University College London, Department of Psychiatry: Liverpool University, Department of Psychiatry: University of Birmingham, Department of Psychiatry: University of Cambridge, Department of Psychiatry: University of Leicester, Department of Psychiatry: University of Southampton, Depression / Dysphoria, Depression in Alzheimer’s Disease Study-II (DIADS)-II, Depression in Dementia, Family Caregivers, Health Services and Population Research Department: King’s College London, Health Technology Assessment Study, HTA-SADD Trial, Hull York Medical School, Institute for Ageing and Health: Newcastle University, Institute of Psychiatry: King's College London, Institute of Rehabilitation: Hull York Medical School, Kings College London, Lancet, Liverpool University, Local Research Ethics Approvals (LREC), Mental Health and Neuroscience Clinical Trials Unit: King’s College London, Mirtazapine, Newcastle University, NIHR Health Technology Assessment Programme, Professor Sube Banerjee, Psychological Symptoms of Dementia (BPSD), Sertraline, Study of Antidepressants for Depression in Dementia (SADD), UK National Institute of Health Research HTA Programme, University College London, University of Birmingham, University of Cambridge, University of East Anglia, University of Leicester, University of Manchester, University of Southampton, University of Sussex, Venlafaxine, Watchful Waiting, Wolfson Centre for Age-Related Disease: King’s College London | Leave a comment

Discontinuation of Antidepressants in People with Dementia and Neuropsychiatric Symptoms (DESEP Study) (BMJ)

Posted on March 21, 2012 by Dementia and Elderly Care News

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 9, April 2012]. Summary Roughly 80% of nursing home residents have dementia in Norway. 90% have neuropsychiatric symptoms. Roughly 40% of residents in Norwegian … Continue reading →

Posted in Acute Hospitals, Community Care, Depression, For Doctors (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments | Tagged Antidepressants, Antidepressants for Depression in Dementia (HTA-SADD), Buddhist Tzu Chi University (Hualien Taiwan), Centre for Old Age Psychiatric Research (Innlandet Hospital Trust), Citalopram, Clinical Dementia Rating Scale, College of Medical Science and Technology: Taipei Medical University, Cornell Scale for Depression in Dementia (CSDD), Department of Dermatology: Wan Fang Hospital, Department of Emergency: Min-Sheng General Hospital, Department of Surgery: Buddhist Tzu Chi University, Depression / Dysphoria, Depression in Older People, Depressive Symptoms, DESEP Study, Escitalopram, Graduate Institute of Biomedical Informatics: Taipei Medical University, Innlandet Hospital Trust (Ottestad; Norway), International Center for Health Information Technology (ICHIT): Taipei Medical University, Lawton and Brody’s Physical Self Maintenance Scale, Min-Sheng General Hospital (Taoyuan City Taiwan), Neuropsychiatric Inventory (NPI), Neuropsychiatric Inventory Scale, Neuropsychiatric Inventory-Nursing Home version (NPI-NH), Neuropsychiatric Symptoms, Norway, Norwegian Centre for Dementia Research, Nursing Home Residents with Dementia, Nursing Home Residents with Dementia (in Norway), Nursing Homes, Paroxetine, Quality of Life-Alzheimer’s Disease Scale, School of Medicine: Buddhist Tzu Chi University, Selective Serotonin Reuptake Inhibitors (SSRIs), Sertraline, Severe Impairment Battery, SSRIs: Selective Serotonin Reuptake Inhibitors, Systematic Reviews and Meta-Analyses, Taipei Medical University, Taiwan, TMU Research Center of Cancer Translational Medicine (Taipei Taiwan), Unified Parkinson’s Disease Rating Scale, University Hospital (Oslo), Wan Fang Hospital (Taipei Taiwan) | Leave a comment

Evidence Update: Treatment of Depression in People With Dementia (NHS Evidence)

Posted on January 23, 2012 by Dementia and Elderly Care News

Summary Depression is common in dementia. It often causes distress, reduces quality of life, worsens cognitive and functional impairment, increases mortality, and also brings about stress and depression in carers. Earlier Guidance The NICE Clinical Guideline on Dementia (CG42) recommends … Continue reading →

Posted in Acute Hospitals, Community Care, Depression, For Doctors (mostly), Guidelines, Management of Condition, National, NHS Evidence, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged Antidepressants, Antidepressants for Depression in Dementia (HTA-SADD), Depression / Dysphoria, Depression in Older People, Mirtazapine, National Institute for Health and Clinical Excellence (NICE), NICE, NICE Clinical Guideline CG90, NICE–SCIE Guideline on Supporting People with Dementia and Their Carers in Health and Social Care, Professor Sube Banerjee, Sertraline | Leave a comment

Health Technology Assessment Study into the Use of Antidepressants for Depression in Dementia (HTA-SADD)

Posted on August 3, 2011 by Dementia and Elderly Care News

[A version of this item appears in: Dementia: the Latest Evidence Newsletter (RWHT), Volume 2 Issue 1, August 2011]. Summary Research into the efficacy and safety of two of the most commonly prescribed drugs, sertraline and mirtazapine, has found that these treatments … Continue reading →

Posted in Acute Hospitals, Community Care, Depression, For Doctors (mostly), For Researchers (mostly), In the News, Management of Condition, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Antidepressants, Antidepressants for Depression in Dementia (HTA-SADD), Cornell Scale for Depression in Dementia (CSDD), Depression / Dysphoria, Health Technology Assessment Study, Mirtazapine, Sertraline, UK National Institute of Health Research HTA Programme | Leave a comment

Tag Archives: Antidepressants for Depression in Dementia (HTA-SADD)

Recent Elderly Mental Health-Related Systematic Reviews and Meta-Analyses

Discontinuation of Antidepressants in People with Dementia and Neuropsychiatric Symptoms (DESEP Study) (BMJ)

Health Technology Assessment Study into the Use of Antidepressants for Depression in Dementia (HTA-SADD)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites